Results 201 to 210 of about 34,981 (267)

Astrocyte heterogeneity in brain metastases

Molecular Oncology, EarlyView.
Astrocytes emerge as pivotal regulators of metastatic colonization, survival, immune remodeling, and therapy response associated with an increasing heterogeneity that requires spatially and longitudinally resolved approaches to uncover regulatory programs and guide context‐specific therapies.
Carolina Hernández‐Oliver, Neibla Priego, Manuel Valiente   +2 more
wiley   +1 more source

Comparison of pharmacokinetics, pharmacodynamics, safety, and immunogenicity of a candidate biosimilar INTP23.1 with EU and US‑approved denosumab reference products in healthy adult men. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Fenwick S, Parekh V, Shah N, Patel R, Kale P, Kolte S.   +5 more
europepmc   +1 more source

From Models to Medicines: A Narrative History and Regulatory Perspective on the Translational Impact of Model-Informed Drug Development (MIDD). [PDF]

Clin Transl Sci
Zineh I.
europepmc   +1 more source

Total thyroidectomy

Journal of British Surgery, 1958
openaire   +2 more sources

From tumor‐centric to ecosystem‐based hypotheses in brain tumor research and care

Molecular Oncology, EarlyView.
Primary brain tumors, whether in adults or children, present a major challenge because of their dramatic prognosis and the ongoing lack of efficient therapeutic approaches. In recent years, a shift has occurred from tumor‐centric concepts to a more holistic view of these tumors as dynamic ecosystems.
Julie Gavard, Flavie Bénard, Eva Billat, Margaux Le Guyon, Victoria Maltret, Laura Merlet, Chloé Astrid Walter, Tony Avril, Eric Chevet   +8 more
wiley   +1 more source

Characterizing the Impacts of 2024 Total Solar Eclipse Using New York State Mesonet Data. [PDF]

Geophys Res Lett
Wang J, Dai A, Yu CL, Shrestha B, McGuinnes DJ, Bain N.   +5 more
europepmc   +1 more source

First-in-Human Explantation for Infection of the Novel Thoracic Branched Endograft. [PDF]

JACC Case Rep
Jimenez Contreras F, Stinson GP, Kohtz PD, Gilmore BF, Upchurch GR, Martin TD.   +5 more
europepmc   +1 more source

Integrated Population Pharmacokinetic, Pharmacodynamic, and Safety Analyses to Inform Dosage Selection in the Clinical Development of the ATR Inhibitor Tuvusertib. [PDF]

Clin Pharmacol Ther
Mukker JK, Diderichsen PM, Hellmann F, Yap TA, Plummer R, Tolcher AW, de Bono JS, Gounaris I, Szucs Z, Zimmermann A, Kareva I, Bolleddula J, Seithel-Keuth A, Locatelli G, Enderlin M, Hicking C, Zutshi A, Gao W, Strotmann R, Benincosa L, Venkatakrishnan K.   +20 more
europepmc   +1 more source